Opioid reversal has another option in its toolkit. In May of 2023 the FDA endorsed Opvee, a nasal spray to reverse an opioid overdose....

Sickle cell disease receives two FDA approved gene therapies in December of 2023 for patients aged 12 years and older. Sickle cell...